In response to the COVID-19 pandemic, a group of physicians and scientists from 34 institutions and 17 states have self-organized into a group known as National COVID-19 Convalescent Plasma Project. Investigating the use of convalescent plasma, as what was a group of biomedical researchers that assembled several years ago to refocus studies of health and disease more directly on public health issues. More than 100 researchers and 40 large hospitals in 20 states are involved in the effort to utilize survivor plasma to clinical trials.
A number of universities, such as University of Wisconsin-Madison, have recently joined the National COVID-19 Convalescent Plasma Project. The group includes big name brand collaborative partners such as Amazon, American Red Cross, and Federal Express.
How did it Start?
Johns Hopkins University professor Arturo Casadevall and Liise-anne Pirofski with Albert Einstein College of Medicine published a paper on March 13, 2020 titled “The convalescent sera option for containing COVID-19” in the Journal of Clinical Investigation. The subject matter immediately generated a response from a group of colleagues connected through various social and profe...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).